Market Summary
USD10.49-0.14
Market Closed-1.32%
PETS Stock Price
PETS RSI Chart
PETS Valuation
PETS Price/Sales (Trailing)
PETS Profitability
PETS Fundamentals
PETS Revenue
PETS Earnings
Price Action
52 Week Range
10.4622.64
(Low)(High)
Last 7 days
-8.8%
Last 30 days
-5.7%
Last 90 days
-23.2%
Trailing 12 Months
-44.5%
PETS Financial Health
PETS Investor Care
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs
Latest Insider Trading transactions for PETS
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-08-14 | Smith Jacqueline Paula | acquired | - | - | 6,000 | - |
2023-08-03 | FULGONI GIAN | acquired | - | - | 7,500 | - |
2023-08-03 | Campbell Leslie C.G. | acquired | - | - | 7,500 | - |
2023-08-03 | Campos Sandra Yvette | acquired | - | - | 7,500 | - |
2023-08-03 | PURCEL DIANA G | acquired | - | - | 7,500 | - |
2023-06-15 | Chambers Christine | acquired | - | - | 11,750 | cfo |
2023-06-08 | Chambers Christine | back to issuer | - | - | -3,000 | cfo |
2023-05-17 | Moseley Mark Bradley JR | acquired | 216,720 | 15.48 | 14,000 | - |
2023-05-17 | Pingree Daniel Job | acquired | 170,280 | 15.48 | 11,000 | - |
2022-07-28 | FULGONI GIAN | acquired | 163,200 | 21.76 | 7,500 | - |
Which funds bought or sold PETS recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-09-20 | BARCLAYS PLC | added | 105 | 608,000 | 1,426,000 | -% |
2023-08-21 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | reduced | -88.56 | -96,000 | 10,000 | -% |
2023-08-21 | OSAIC HOLDINGS, INC. | added | 6.43 | -20,865 | 195,698 | -% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | added | 1.25 | -57,103 | 350,018 | -% |
2023-08-16 | Nuveen Asset Management, LLC | unchanged | - | -146,096 | 822,904 | -% |
2023-08-15 | GOLDMAN SACHS GROUP INC | added | 33.03 | 389,502 | 3,394,970 | -% |
2023-08-15 | WELLS FARGO & COMPANY/MN | added | 28.74 | 15,255 | 179,211 | -% |
2023-08-15 | CONNORS INVESTOR SERVICES INC | added | 3.04 | -327,000 | 2,287,000 | 0.26% |
2023-08-15 | Belpointe Asset Management LLC | sold off | -100 | -430 | - | -% |
2023-08-15 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | added | 5.01 | -1,000 | 10,000 | -% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Schedule 13G FIlings of Petmed Express
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Jul 07, 2023 | blackrock inc. | 8.0% | 1,694,462 | SC 13G/A | |
| Feb 09, 2023 | vanguard group inc | 7.04% | 1,483,238 | SC 13G/A | |
| Jan 26, 2023 | proshare advisors llc | 3.2% | 649,277 | SC 13G/A | |
| Jan 23, 2023 | blackrock inc. | 16.5% | 3,473,358 | SC 13G/A | |
| Jan 27, 2022 | blackrock inc. | 15.7% | 3,290,803 | SC 13G/A | |
| Jan 26, 2022 | blackrock inc. | 15.7% | 3,290,803 | SC 13G | |
| Feb 11, 2021 | renaissance technologies llc | 6.21% | 1,258,073 | SC 13G/A | |
| Feb 10, 2021 | vanguard group inc | 7.74% | 1,569,843 | SC 13G/A | |
| Jan 25, 2021 | blackrock inc. | 15.4% | 3,131,671 | SC 13G | |
| Feb 13, 2020 | renaissance technologies llc | 8.02% | 1,616,400 | SC 13G/A |
Recent SEC filings of Petmed Express
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Aug 30, 2023 | S-8 POS | Employee Benefits Plan | |
| Aug 30, 2023 | S-8 POS | Employee Benefits Plan | |
| Aug 28, 2023 | S-8 POS | Employee Benefits Plan | |
| Aug 28, 2023 | S-8 POS | Employee Benefits Plan | |
| Aug 16, 2023 | 4 | Insider Trading | |
| Aug 16, 2023 | 4 | Insider Trading | |
| Aug 04, 2023 | 4 | Insider Trading | |
| Aug 04, 2023 | 4 | Insider Trading | |
| Aug 04, 2023 | 4 | Insider Trading | |
| Aug 04, 2023 | 4 | Insider Trading |
Peers (Alternatives to Petmed Express)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
AMZN | 1.3T | 538.0B | -5.46% | 9.41% | 99.39 | 2.41 | 10.73% | 12.62% |
EBAY | 22.9B | 9.9B | -0.23% | 14.06% | 17.05 | 2.3 | -0.79% | 271.47% |
ETSY | 7.6B | 2.7B | -14.44% | -34.39% | -10.64 | 2.86 | 9.87% | -816.12% |
CHWY | 7.6B | 10.8B | -31.37% | -44.84% | 152.87 | 0.7 | 14.19% | 190.02% |
| MID-CAP | ||||||||
W | 6.4B | 11.9B | -12.78% | 59.14% | -6.15 | 0.54 | -6.04% | -5.94% |
| SMALL-CAP | ||||||||
RVLV | 948.1M | 1.1B | -11.76% | -46.19% | 22.94 | 0.88 | 2.25% | -51.31% |
OSTK | 737.2M | 1.7B | -34.05% | -30.12% | -5.41 | 0.44 | -29.49% | -269.03% |
SFIX | 404.1M | 1.6B | -5.15% | -11.17% | -2.35 | 0.25 | -20.96% | 16.97% |
LE | 239.4M | 1.5B | -18.56% | -6.98% | -13.56 | 0.16 | -3.31% | -277.23% |
PETS | 225.0M | 264.9M | -5.68% | -44.53% | -65.63 | 0.85 | 0.24% | -117.63% |
REAL | 210.4M | 575.1M | -11.97% | 35.53% | -1 | 0.37 | 1.77% | 4.67% |
DLTH | 189.3M | 651.8M | -22.33% | -19.69% | -40.77 | 0.29 | -4.22% | -121.89% |
IMBI | 6.5M | - | -42.26% | -92.03% | -0.15 | 0.01 | - | - |
Petmed Express News
Returns for PETS
Cumulative Returns on PETS
-0.5%
10-Year Cumulative Returns
-5.6%
7-Year Cumulative Returns
-17.9%
5-Year Cumulative Returns
-27.5%
3-Year Cumulative Returns
Risks for PETS
What is the probability of a big loss on PETS?
95.8%
Probability that Petmed Express stock will be more than 20% underwater in next one year
65.4%
Probability that Petmed Express stock will be more than 30% underwater in next one year.
28.1%
Probability that Petmed Express stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does PETS drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Petmed Express was unfortunately bought at previous high price.
Drawdowns
Financials for Petmed Express
Income Statement (Last 12 Months)(In Millions)
| Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Revenue | 3.1% | 265 | 257 | 260 | 262 | 264 | 273 | 279 | 284 | 292 | 309 | 312 | 306 | 300 | 284 | 274 | 275 | 276 | 283 | 286 | 286 | 282 |
| Gross Profit | 3.6% | 74.00 | 71.00 | 73.00 | 76.00 | 76.00 | 78.00 | 79.00 | 81.00 | 85.00 | 90.00 | 91.00 | 89.00 | 86.00 | 81.00 | 80.00 | 82.00 | 87.00 | 95.00 | 100 | 102 | 100 |
| Operating Expenses | 11.3% | 81.00 | 72.00 | 60.00 | 57.00 | 52.00 | 52.00 | 52.00 | 50.00 | 51.00 | 52.00 | 53.00 | 53.00 | 52.00 | 50.00 | 50.00 | 50.00 | 51.00 | 49.00 | 47.00 | 48.00 | 47.00 |
| S&GA Expenses | 12.9% | 56.00 | 49.00 | 39.00 | 36.00 | 32.00 | 31.00 | 30.00 | 29.00 | 29.00 | 28.00 | 27.00 | 27.00 | 27.00 | 25.00 | 25.00 | 24.00 | 24.00 | 25.00 | 25.00 | 25.00 | 25.00 |
| EBITDA | -100.0% | - | 5.00 | 18.00 | 23.00 | 28.00 | 30.00 | 31.00 | 35.00 | 38.00 | 39.00 | 39.00 | 38.00 | 37.00 | 34.00 | 33.00 | - | - | - | - | - | - |
| EBITDA Margin | -100.0% | - | 0.02* | 0.07* | 0.09* | 0.11* | 0.11* | 0.11* | 0.12* | 0.13* | 0.13* | 0.13* | 0.13* | 0.12* | 0.12* | 0.12* | - | - | - | - | - | - |
| Earnings Before Taxes | -303.5% | -3.22 | 2.00 | 15.00 | 20.00 | 25.00 | 27.00 | 28.00 | 33.00 | 35.00 | 39.00 | 39.00 | 38.00 | 37.00 | 34.00 | 33.00 | 35.00 | 40.00 | 49.00 | 55.00 | 57.00 | 56.00 |
| EBT Margin | -100.0% | - | 0.01* | 0.06* | 0.08* | 0.09* | 0.10* | 0.10* | 0.11* | 0.12* | 0.13* | 0.13* | 0.13* | 0.12* | 0.12* | 0.12* | - | - | - | - | - | - |
| Net Income | -1571.7% | -3.43 | 0.00 | 11.00 | 16.00 | 19.00 | 21.00 | 22.00 | 25.00 | 27.00 | 31.00 | 31.00 | 30.00 | 28.00 | 26.00 | 25.00 | 26.00 | 31.00 | 38.00 | 41.00 | 43.00 | 41.00 |
| Net Income Margin | -100.0% | - | 0.00* | 0.04* | 0.06* | 0.07* | 0.08* | 0.08* | 0.09* | 0.09* | 0.10* | 0.10* | 0.10* | 0.09* | 0.09* | 0.09* | - | - | - | - | - | - |
| Free Cashflow | -100.0% | - | 23.00 | 23.00 | 19.00 | 23.00 | 17.00 | 26.00 | 24.00 | 48.00 | 38.00 | 37.00 | 34.00 | 25.00 | 37.00 | 33.00 | - | - | - | - | - | - |
Balance Sheet(In Millions)
| Balance Sheet | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Assets | 10.1% | 181 | 164 | 165 | 169 | 165 | 176 | 168 | 159 | 173 | 187 | 167 | 159 | 163 | 155 | 150 | 146 | 145 | 154 | 157 | 148 | 153 |
| Current Assets | -19.5% | 106 | 131 | 134 | 138 | 134 | 151 | 143 | 133 | 147 | 161 | 141 | 133 | 136 | 129 | 123 | 118 | 117 | 126 | 128 | 119 | 123 |
| Cash Equivalents | -40.9% | 62.00 | 104 | 102 | 97.00 | 105 | 111 | 109 | 107 | 112 | 119 | 107 | 106 | 87.00 | 104 | 92.00 | 95.00 | 83.00 | 101 | 93.00 | 87.00 | 95.00 |
| Net PPE | 3.9% | 27.00 | 26.00 | 25.00 | 25.00 | 25.00 | 24.00 | 25.00 | 25.00 | 25.00 | 25.00 | 26.00 | 25.00 | 26.00 | 25.00 | 26.00 | 26.00 | 27.00 | 27.00 | 28.00 | 28.00 | 28.00 |
| Goodwill | - | 21.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Liabilities | 54.8% | 62.00 | 40.00 | 32.00 | 31.00 | 25.00 | 34.00 | 28.00 | 18.00 | 33.00 | 46.00 | 28.00 | 23.00 | 30.00 | 25.00 | 22.00 | 20.00 | 21.00 | 20.00 | 24.00 | 18.00 | 29.00 |
| Current Liabilities | 57.1% | 57.00 | 36.00 | 31.00 | 31.00 | 24.00 | 33.00 | 26.00 | 16.00 | 32.00 | 45.00 | 27.00 | 21.00 | 29.00 | 24.00 | 21.00 | 19.00 | 20.00 | 19.00 | 23.00 | 17.00 | 28.00 |
| Shareholder's Equity | -4.4% | 118 | 124 | 134 | 138 | 140 | 142 | 141 | 141 | 140 | 141 | 139 | 136 | 133 | 130 | 128 | 126 | 124 | 135 | 133 | 130 | 124 |
| Retained Earnings | -6.9% | 98.00 | 105 | 117 | 123 | 127 | 130 | 131 | 133 | 132 | 134 | 133 | 131 | 128 | 126 | 125 | 123 | 122 | 122 | 121 | 119 | 114 |
| Additional Paid-In Capital | 9.6% | 20.00 | 18.00 | 17.00 | 15.00 | 13.00 | 12.00 | 10.00 | 9.00 | 8.00 | 7.00 | 6.00 | 5.00 | 5.00 | 4.00 | 3.00 | 2.00 | 2.00 | 12.00 | 12.00 | 11.00 | 10.00 |
| Shares Outstanding | 0.4% | 21.00 | 21.00 | 21.00 | 21.00 | 20.00 | 21.00 | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 | 21.00 | 20.00 | 20.00 | 20.00 |
Cashflow (Last 12 Months)(In Millions)
| Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Cashflow From Operations | -20.9% | 22.00 | 28.00 | 27.00 | 23.00 | 25.00 | 18.00 | 28.00 | 26.00 | 51.00 | 40.00 | 39.00 | 37.00 | 28.00 | 39.00 | 35.00 | 42.00 | 23.00 | 45.00 | 34.00 | 39.00 | 46.00 |
| Share Based Compensation | 3.4% | 7.00 | 7.00 | 6.00 | 6.00 | 5.00 | 5.00 | 4.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
| Cashflow From Investing | -302.4% | -41.29 | -10.26 | -8.81 | -8.12 | -7.26 | -1.75 | -1.85 | -2.21 | -2.76 | -2.43 | -2.33 | -3.09 | -2.26 | -2.31 | -1.94 | -0.59 | -0.51 | -0.62 | -0.65 | -0.80 | -0.97 |
| Cashflow From Financing | -0.2% | -24.57 | -24.54 | -24.46 | -24.43 | -24.41 | -24.38 | -23.97 | -23.53 | -23.13 | -22.69 | -22.43 | -22.20 | -21.92 | -33.30 | -33.54 | -33.68 | -33.80 | -21.92 | -21.44 | -19.99 | -18.51 |
| Dividend Payments | 0.2% | 25.00 | 25.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 23.00 | 23.00 | 22.00 | 22.00 | 22.00 | 22.00 | 22.00 | 22.00 | 22.00 | 22.00 | 21.00 | 20.00 | 19.00 |
| Buy Backs | - | - | - | - | - | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 | 11.00 | 15.00 | 23.00 | 46.00 | - | - | - | - |
PETS Income Statement
2023-06-30Condensed Consolidated Statements of (Loss) Income - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | |
| Income Statement [Abstract] | ||
| Sales | $ 78,244 | $ 70,187 |
| Cost of sales | 55,718 | 50,244 |
| Gross profit | 22,526 | 19,943 |
| Operating expenses: | ||
| General and administrative | 15,711 | 9,351 |
| Advertising | 7,265 | 6,349 |
| Depreciation and amortization | 1,678 | 753 |
| Total operating expenses | 24,654 | 16,453 |
| (Loss) income from operations | (2,128) | 3,490 |
| Other income: | ||
| Interest income, net | 620 | 117 |
| Other, net | 506 | 198 |
| Total other income | 1,126 | 315 |
| (Loss) income before (benefit) provision for income taxes | (1,002) | 3,805 |
| (Benefit) provision for income taxes | (115) | 1,030 |
| Net (loss) income | $ (887) | $ 2,775 |
| Net (loss) income per common share: | ||
| Basic (in dollars per share) | $ (0.04) | $ 0.14 |
| Diluted (in dollars per share) | $ (0.04) | $ 0.14 |
| Weighted average number of common shares outstanding: | ||
| Basic (in shares) | 20,333 | 20,208 |
| Diluted (in shares) | 20,333 | 20,291 |
| Cash dividends declared per common share (in dollars per share) | $ 0.30 | $ 0.30 |
PETS Balance Sheet
2023-06-30Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2023 | Mar. 31, 2023 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 61,534 | $ 104,086 |
| Accounts receivable, less allowance for doubtful accounts of $38 and $35, respectively | 1,894 | 1,740 |
| Inventories - finished goods | 32,324 | 19,023 |
| Prepaid expenses and other current assets | 8,530 | 4,719 |
| Prepaid income taxes | 1,548 | 1,883 |
| Total current assets | 105,830 | 131,451 |
| Noncurrent assets: | ||
| Property and equipment, net | 27,207 | 26,178 |
| Intangible and other assets, net | 17,671 | 5,860 |
| Goodwill | 20,735 | 0 |
| Operating lease right-of-use assets, net | 2,024 | 0 |
| Deferred tax assets, net | 7,270 | 628 |
| Total noncurrent assets | 74,907 | 32,666 |
| Total assets | 180,737 | 164,117 |
| Current liabilities: | ||
| Accounts payable | 40,037 | 25,208 |
| Accrued expenses and other current liabilities | 13,240 | 11,289 |
| Current lease liabilities | 799 | 0 |
| Deferred revenue | 3,246 | 0 |
| Total current liabilities | 57,322 | 36,497 |
| Long-term lease liabilities | 1,268 | 0 |
| Other long-term liabilities | 3,825 | 3,825 |
| Total liabilities | 62,415 | 40,322 |
| Commitments and contingencies (Note 9) | ||
| Shareholders' equity: | ||
| Preferred stock, $.001 par value, 5,000 shares authorized; 3 convertible shares issued and outstanding with a liquidation preference of $4 per share | 9 | 9 |
| Common stock, $.001 par value, 40,000 shares authorized; 21,170 and 21,084 shares issued and outstanding, respectively | 21 | 21 |
| Additional paid-in capital | 20,037 | 18,277 |
| Retained earnings | 98,255 | 105,488 |
| Total shareholders' equity | 118,322 | 123,795 |
| Total liabilities and shareholders' equity | $ 180,737 | $ 164,117 |
PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies. It sells its products through its Internet website and mobile app; telephone contact center; and direct mail/print through catalogs, brochures, and postcards. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.